Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Piroth

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 26, 2013
[Risks of unfavorable cosmetic and toxicity after percutaneous accelerated partial breast irradiation (APBI). Interim analysis from the Canadian RAPID trial]M D Piroth
Onkologie|November 5, 2002
Radiation recall dermatitis from docetaxelM D Piroth, R Krempien, M Wannenmacher, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 10, 2013
Treatment planning after hydrogel injection during radiotherapy of prostate cancerM Pinkawa, C Bornemann, N Escobar-Corral, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 16, 2025
De-escalation strategies in early breast cancer: implications of sentinel lymph node biopsy omission for adjuvant radiotherapyK J Borm, J Hörner-Rieber, N M Duma, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 31, 2012
Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysisM Pinkawa, M D Piroth, R Holy, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2012
Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II studyM D Piroth, M Pinkawa, R Holy, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2014
How nescience may obscure evidenceM-L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 31, 2025
DEGRO statement on the FAST-Forward trial: 10-year data of ultrahypofractionated radiation therapy for breast cancerC Matuschek, K Borm, J Hörner-Rieber, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2016
DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrencesWolfgang Harms, W Budach, J Dunst, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 19, 2014
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathwaysM-L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 26, 2013
[Risks of unfavorable cosmetic and toxicity after percutaneous accelerated partial breast irradiation (APBI). Interim analysis from the Canadian RAPID trial]M D Piroth
Onkologie|November 5, 2002
Radiation recall dermatitis from docetaxelM D Piroth, R Krempien, M Wannenmacher, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 10, 2013
Treatment planning after hydrogel injection during radiotherapy of prostate cancerM Pinkawa, C Bornemann, N Escobar-Corral, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 16, 2025
De-escalation strategies in early breast cancer: implications of sentinel lymph node biopsy omission for adjuvant radiotherapyK J Borm, J Hörner-Rieber, N M Duma, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 31, 2012
Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysisM Pinkawa, M D Piroth, R Holy, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2012
Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II studyM D Piroth, M Pinkawa, R Holy, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2014
How nescience may obscure evidenceM-L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 31, 2025
DEGRO statement on the FAST-Forward trial: 10-year data of ultrahypofractionated radiation therapy for breast cancerC Matuschek, K Borm, J Hörner-Rieber, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2016
DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrencesWolfgang Harms, W Budach, J Dunst, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 19, 2014
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathwaysM-L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Pageof 2